Rising Use of Weight Loss Drugs Raises Employer Costs

The popularity of weight loss drugs, especially GLP-1 medications, among workers with employer health insurance is increasing, leading to higher costs for employers and prompting some to reconsider coverage policies. Larger firms are more likely to cover these drugs, but rising usage and prices are impacting their budgets, potentially affecting future insurance premiums and employee costs.